ANG Lifesciences India Limited Submits SEBI Compliance Certificate for Q4 FY26
ANG Lifesciences India Limited has submitted its quarterly compliance certificate under SEBI Regulation 74(5) for Q4 FY26 ended March 31, 2026. The certificate, confirmed by Registrar Bigshare Services Private Limited, validates proper dematerialization processes and regulatory compliance. Managing Director Rajesh Gupta submitted the documentation to BSE Limited on April 15, 2026, ensuring continued adherence to depository regulations.
*this image is generated using AI for illustrative purposes only.
ANG Lifesciences India Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories & Participants) Regulations, 2018. The pharmaceutical company, trading under BSE Security Code 540694, completed this mandatory filing for the quarter ended March 31, 2026.
Regulatory Compliance Certificate Details
The compliance certificate was issued under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, covering the quarter ended March 31, 2026. Managing Director Rajesh Gupta (DIN: 01423407) submitted the certificate to BSE Limited on April 15, 2026, through reference number ANh/26-27/225.
| Parameter: | Details |
|---|---|
| Quarter Period: | March 31, 2026 |
| Submission Date: | April 15, 2026 |
| BSE Security Code: | 540694 |
| ISIN: | INE236W01016 |
| Submitted By: | Rajesh Gupta, Managing Director |
Registrar Confirmation
Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent (RTA), issued the confirmation certificate on April 10, 2026. The RTA confirmed compliance with dematerialization requirements and proper handling of securities received from depository participants.
The certificate confirms that:
- Securities received from depository participants for dematerialization up to March 31, 2026 were properly confirmed to depositories
- All securities have been listed on stock exchanges where earlier issued securities are listed
- Security certificates received for dematerialization have been mutilated and cancelled after due verification
- Depository names have been substituted in the register of members as registered owners within 15 days of receipt
Corporate Information
ANG Lifesciences India Limited operates under CIN L24230PB2006PLC030341 and GST number 02AAHCA5390H2ZT. The company is headquartered at SCO-113 Darbara Complex, B-Block Rabjit Avenue, Amritsar-143001. This quarterly submission demonstrates the company's commitment to maintaining regulatory compliance and transparency in its depository operations.
The submission of this certificate ensures ANG Lifesciences remains compliant with SEBI regulations governing depositories and participants, maintaining its good standing with regulatory authorities and stock exchange requirements.
Historical Stock Returns for ANG Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
What strategic initiatives might ANG Lifesciences pursue in FY 2026-27 following this regulatory compliance milestone?
How could ANG Lifesciences' consistent regulatory compliance impact its ability to attract institutional investors or strategic partnerships?
Will ANG Lifesciences consider expanding its stock exchange listings beyond BSE to enhance liquidity and market presence?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
